It is likely that the variable response of
these cells to the drug treatment might be a result of distinct genetic
alterations of multiple oncogenic pathways. Another possible
explanation for the discrepancy of our results could lie in the differences
in the growth rate and the degree of aggressiveness of the
tested cells.